Premier Funding and Financial Marketing Services

CytoCore, originally incorporated as Premier Funding and Financial Marketing Services, was a biotechnology company focused on the development of advanced oncology diagnostics. The company primarily specialized in cervical cancer screening technologies, most notably the InPath system, which utilized automated imaging and molecular markers to improve the accuracy of early detection. Additionally, CytoCore developed the SoftPap cervical cell collector, a medical device designed to enhance the quality of cellular samples obtained during routine examinations. Despite its efforts to commercialize these diagnostic platforms, the company faced significant financial and regulatory challenges, eventually becoming inactive and ceasing operations in the early 2010s.